KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,809,000 | +56.4% | 27,100 | +18.5% | 0.20% | +55.9% |
| Q1 2017 | $1,796,000 | -42.7% | 22,871 | -59.2% | 0.13% | -38.9% |
| Q3 2016 | $3,132,000 | +69.8% | 56,066 | +52.0% | 0.21% | +62.5% |
| Q2 2016 | $1,845,000 | +37.7% | 36,897 | +26.4% | 0.13% | +30.6% |
| Q1 2016 | $1,340,000 | -29.1% | 29,181 | -14.0% | 0.10% | -27.4% |
| Q3 2015 | $1,889,000 | -1.2% | 33,919 | +8.2% | 0.14% | +10.7% |
| Q2 2015 | $1,912,000 | – | 31,354 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $108,260,000 | 37.66% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,479,000 | 8.02% |
| RTW INVESTMENTS, LP | 343,503 | $15,770,000 | 5.72% |
| DSAM Partners (London) Ltd | 256,550 | $11,778,000 | 5.26% |
| Silver Rock Financial LLC | 109,199 | $5,013,000 | 5.09% |
| Casdin Capital, LLC | 75,000 | $3,443,000 | 3.95% |
| EcoR1 Capital, LLC | 150,000 | $6,887,000 | 2.41% |
| Vivo Capital, LLC | 193,193 | $8,869,000 | 2.22% |
| BB BIOTECH AG | 750,000 | $34,433,000 | 1.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 494,988 | $22,725,000 | 1.36% |